SkinCeuticals USA names GM, VP of business strategy and growth

SkinCeuticals USA has named Angela Hildebrand as general manager, as well as Amy Sloan as senior VP of business strategy and growth.

Hildebrand brings 20 years of experience in the aesthetic industry to the medical aesthetic skincare brand owned by L’Oréal. Most recently, she was the general manager of medical commercial strategy at L’Oréal Dermatological Beauty, where she led strategy on medical acceleration projects with Tina Fair, president, L’Oréal Dermatological Beauty Division, North America.

Prior to that, she had an eight-year tenure as the SkinCeuticals SVP of sales, where she led the U.S. sales team to produce record breaking results, among other initiatives. 

“As SkinCeuticals continues to exponentially grow and our distribution model continuously evolves at such rapid rates, it is without a doubt that, together with Tina, Amy and the entire team, we will usher our brand and the entire medical skincare market to the next level,” said Hildebrand.

Likewise, as senior VP of business strategy and growth, Sloan will focus on strategic growth initiatives and continued leadership of the marketing, retail, digital/e-retail, and advocacy & influence teams to maintain momentum with product innovation, services, business models and partnerships, and consumer experience across all channels.

“This next chapter in my SkinCeuticals career is an exciting one,” Sloan added. “With Angela at the helm, we will work hand-in-hand to ensure our doctors, their patients, and all consumers have the best omnichannel experience to our advanced skincare backed by science.”